Document:

exv4w1

 

EXHIBIT 4.1

AMENDMENT NO. 1 TO RIGHTS AGREEMENT

     THIS AMENDMENT NO. 1 (the “Amendment”), dated as of May 31, 2006, to the Rights Agreement (the
“Rights Agreement”), dated as of March 15, 2006, between EMAK Worldwide, Inc., a Delaware
corporation (the “Company”) and Continental Stock Transfer & Trust Company (the “Rights Agent”), is
being executed at the direction of the Company.

     WHEREAS, Section 27 of the Rights Agreement permits the Company from time to time to
supplement and amend the Rights Agreement.

     NOW, THEREFORE, in consideration of the foregoing and the agreements, provisions and covenants
herein contained, the parties agree as follows:

	1.	 	The defined term “Acquiring Person” in Section 1(a) of the Rights Agreement is hereby deleted
in its entirety and replaced with the following:

          (i) “Acquiring Person” shall mean any Person (as such term is hereinafter defined) who or
which, together with all Affiliates and Associates (as such terms are hereinafter defined) of such
Person, shall be the Beneficial Owner (as such term is hereinafter defined) of 10% or more of the
Common Shares then outstanding. Notwithstanding the foregoing, (A) the term Acquiring Person shall
not include (i) the Company, (ii) any Subsidiary (as such term is hereinafter defined) of the
Company, (iii) any employee benefit or compensation plan of the Company or any Subsidiary of the
Company, (iv) any entity holding Common Shares for or pursuant to the terms of any such employee
benefit or compensation plan of the Company or any Subsidiary of the Company, (B) if, as of the
date of this Agreement, any Person is the Beneficial Owner of 10% or more of the Common Shares
outstanding (an “Existing Holder”), such Existing Holder shall not be or become an “Acquiring
Person” unless and until such time as such Existing Holder shall become the Beneficial Owner of one
or more additional Common Shares (other than pursuant to a dividend or distribution paid or made by
the Company on the outstanding Common Shares in Common Shares or pursuant to a split or subdivision
of the outstanding Common Shares or pursuant to any award granted by the Company under an
equity-based compensation plan), unless, upon becoming the Beneficial Owner of such additional
Common Shares, such Existing Holder is not then the Beneficial Owner of 10% or more of the Common
Shares then outstanding, (C) Crown EMAK Partners LLC and its Affiliates (“Crown”) shall not be or
become an “Acquiring Person” solely as a result of Common Shares Beneficially Owned by Crown or
issuable upon the conversion of shares of Series AA Senior Cumulative Convertible Preferred Stock,
par value $.001 per share, of the Company (as the same may be amended from time to time) or the
exercise of any options or warrants Crown holds to acquire capital stock of the Company (as the
same may be amended from time to time), in each case held by Crown as of May 31, 2006 or issuable
to Crown as a result of the transactions approved by the Company’s stockholders at the Company’s
2006 Annual Meeting of Stockholders, unless and until such time as Crown shall become the
Beneficial Owner of one or more additional Common Shares (other than pursuant to a dividend or
distribution paid or made by the Company on the outstanding Common Shares in Common Shares or
pursuant to a split or subdivision of the outstanding Common Shares), unless, upon becoming the
Beneficial Owner of such additional Common Shares, Crown is not then the Beneficial Owner of 10% or
more of the Common Shares then outstanding and (D) no Person shall become an “Acquiring Person”
either (x) as the

1.

 

result of an acquisition of Common Shares by the Company which, by reducing the number of
shares outstanding, increases the proportionate number of shares beneficially owned by such Person
to 10% or more of the Common Shares then outstanding; provided, however, that if a Person shall
become the Beneficial Owner of 10% or more of the Common Shares then outstanding by reason of share
purchases by the Company and shall, following written notice from, or public disclosure by the
Company of such share purchases by the Company, become the Beneficial Owner of any additional
Common Shares without the prior consent of the Company and shall then Beneficially Own more than
10% of the Common Shares then outstanding, then such Person shall be deemed to be an “Acquiring
Person,” or (y) as the result of the acquisition of Common Shares directly from the Company as long
as, prior to any acquisition of Common Shares directly from the Company, the Company has been
apprised by any such Person of the number of Common Shares beneficially owned by such Person
immediately prior to any such acquisition; provided, however, that if a Person shall become the
Beneficial Owner of 10% or more of the Common Shares then outstanding by reason of share purchases
directly from the Company and shall, after that date, become the Beneficial Owner of any additional
Common Shares without the prior written consent of the Company and shall then Beneficially Own more
than 10% of the Common Shares then outstanding, then such Person shall be deemed to be an
“Acquiring Person” or (z) if the Board of Directors determines in good faith that a Person who
would otherwise be an “Acquiring Person,” as defined pursuant to the foregoing provisions of this
paragraph (a), has become such inadvertently, and without any intention of changing or influencing
control of the Company, and such Person promptly enters into an irrevocable written commitment in
favor of the Company to divest, and thereafter divests (without retaining any power, including
voting with respect to such Common Shares), as promptly as practicable (as determined in good faith
by the Board of Directors), following receipt of written notice from the Company of such event, of
Beneficial Ownership of a sufficient number of Common Shares so that such Person would no longer be
an Acquiring Person, as defined pursuant to the foregoing provisions of this paragraph (a), then
such Person shall not be deemed to be an “Acquiring Person” for any purposes of this Agreement;
provided, however, that if such Person shall again become the Beneficial Owner of 10% or more of
the Common Shares then outstanding, such Person shall be deemed an “Acquiring Person,” subject to
the exceptions set forth in this Section 1(a).”

	2.	 	This Amendment shall become effective as of the day and year first written above. Except as
modified by this Amendment, the Rights Agreement shall remain in full force and effect without
any modification.
	 
	3.	 	By executing this Amendment below, the Company certifies that this Amendment has been
executed and delivered in compliance with the terms of Section 27 of the Rights Agreement.
	 
	4.	 	This Amendment may be executed in several counterparts, each of which shall constitute an
original and all of which, when taken together, shall constitute one agreement.

2.

 

     The parties hereto have caused this Amendment to be executed and delivered as of the day and
year first written above.

	 	 	 	 	 
	 	EMAK WORLDWIDE, INC.

 	 
	 	By:  	/s/
TERESA L. TORMEY
 	 
	 	Name:  	Teresa L. Tormey 	 
	 	Title:  	Chief Administrative Officer & General Counsel 	 
	 
 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY

 	 
	 	By:  	/s/
WILLIAM F. SEEGRABER
 	 
	 	Name:  	William F. Seegraber 	 
	 	Title:  	Vice President 	 
	 

3.exv10w1

 

EXHIBIT
10.1

EXCHANGE AND EXTENSION AGREEMENT

     THIS EXCHANGE AND EXTENSION AGREEMENT (“Agreement”) is made and entered into as of June 30,
2006 by and between Crown EMAK Partners, LLC, a Delaware limited liability company (the
“Investor”), and EMAK Worldwide, Inc., a Delaware corporation (the “Company”).

RECITALS

     A. The Investor and the Company entered into a Securities Purchase Agreement, dated as of
March 29, 2000 (the “Purchase Agreement”), pursuant to which the Investor acquired an aggregate of
25,000 shares of Series A mandatorily redeemable senior cumulative participating convertible
preferred stock, par value $.001 per share, (the “Series A Stock”). In connection with such
purchase, the Company granted to the Investor five year warrants (collectively, the “Preferred
Warrants”) to purchase shares of Series B senior cumulative participating convertible preferred
stock, par value $.001 per share, (the “Series B Stock”), and Series C senior cumulative
participating convertible preferred stock, par value $.001 per share, (the “Series C Stock”).

     B. On March 19, 2004, the Company and the Investor entered into a Warrant Exchange Agreement
whereby the Investor received new warrants to purchase an aggregate of 916,666 shares of Common
Stock (“Common Warrants”) in exchange for cancellation of the existing Preferred Warrants (which
would also have been convertible into 916,666 shares of Common Stock) (the “Exchange Transaction”).
As a result of the Exchange Transaction, the Investor received an extension of time in which to
exercise its right to purchase additional equity in the Company, and the Company obtained an
elimination of the preferred rights and preferences as well as the preferred dividend associated
with the Series B Stock and Series C Stock.

     C. On December 30, 2004, the Company entered into an Exchange Agreement with the Investor
whereby the Investor received 25,000 shares of Series AA mandatorily redeemable senior cumulative
preferred stock, par value $0.001 per share, (the “Series AA Stock”) in exchange for 25,000 shares
of Series A Stock. Also on December 30, 2004, the Company filed with the Delaware Secretary of
State a Certificate of Designation of Series AA Senior Cumulative Convertible Preferred Stock (the
“Certificate of Designation”).

     D. The Investor and the Company now desire to provide for certain modifications to the rights
and preferences of the Series AA Stock, as well as for the amendment of the Common Warrants,
pursuant to the terms and conditions set forth in this Agreement (the “Transactions”).

     E. The Investor and the Company intend that the amendment of the Common Warrants be exempt
from registration pursuant to Section 3(a)(9) of the Securities Act of 1933, as amended.

     For good and valuable consideration, the receipt and adequacy of which are hereby
acknowledged, the Company and the Investor hereby agree as follows:

1

 

     1. Exchange of Rights and Obligations under Certificate of Designation.

     1.1 Elimination of Preferred Dividend. Upon the terms and subject to the
conditions hereof, the Investor agrees to the elimination of the 6% cumulative dividend on
the Series AA Stock effective as of April 1, 2006 (after accrual of the March 31, 2006
dividend, which remains due and will continue to accrue interest at 6% per annum, compounded
quarterly, until paid). The elimination of the dividend will be effected pursuant to an
amendment to the Certificate of Designation in the form attached hereto as Exhibit A
(the “Amended Series AA Certificate”).

     1.2 Reduction of Conversion Price. Upon the terms and subject to the
conditions hereof, the Company agrees to change the Conversion Price (as defined in the
Certificate of Designation) of the Series AA Stock from Fourteen Dollars and Seventy-Five
Cents ($14.75) per share to Nine Dollars ($9.00) per share. The change in the Conversion
Price will be effected pursuant to the Amended Series AA Certificate.

     1.3 Extension of Common Warrants. Upon the terms and subject to the conditions
hereof, the Company agrees that effective upon the Closing (as defined in Section 2.1
below), the expiration date of each of the Common Warrants to purchase shares of Common
Stock (“Warrant Shares”), shall be extended for two (2) years, as set forth below:

	 	 	 	 	 	 	 
	Number of	 	Exercise Price	 	Current	 	New
	Warrant Shares	 	Per Share	 	Expiration Date	 	Expiration Date
	357,000
	 	$16.00
	 	March 29, 2010
	 	March 29, 2012
	  79,333
	 	$18.00
	 	March 29, 2010
	 	March 29, 2012
	393,000
	 	$16.00
	 	June 20, 2010
	 	June 20, 2012
	  87,333
	 	$18.00
	 	June 20, 2010
	 	June 20, 2012

     1.4 Change of Voting Rights for Preferred Directors. Upon and subject to the
conditions hereof, the Investor agrees to amendment of the rights of the holders Series AA
Stock pertaining to election of Series AA Directors to permit the designation of two
directors unless the number of Common Directors exceeds seven, except in situations
involving a potential Change of Control (as defined in the Certificate of Designation)
triggering the right to appoint a third director. The change in the voting rights for
preferred directors is subject to the approval of the Company’s stockholders and will be
effected pursuant to the Amended Series AA Certificate.

     2. Closing.

     2.1 The closing of the Transactions (the “Closing”) will occur as soon as reasonably
practicable following delivery of (i) the Rights Amendment (as defined in Section 3.8
below), (ii) drafts of the various filings to be made pursuant to federal securities laws
with respect to consummation of the Transactions, and (iii) the opinion of the Company’s
general counsel in substantially the form attached hereto as Exhibit B, in

2

 

each case in form and substance reasonably satisfactory to the Investor (together, the
“Closing Conditions”).

     2.2 Upon satisfaction of the Closing Conditions, the Investor, by its execution of this
Agreement, hereby consents to the amendment of the Certificate of Designation and the filing
of the Amended Series AA Certificate with the Delaware Secretary of State.

     2.3 Upon satisfaction of the Closing Conditions, the Company agrees to cause to be
filed with the Delaware Secretary of State the Amended Series AA Certificate.

     2.4 All acts, deliveries and confirmations comprising the Closing regardless of
chronological sequence shall be deemed to occur contemporaneously and simultaneously upon
the occurrence of the last act, delivery of confirmation of the Closing and none of such
acts, deliveries or confirmations shall be effective unless and until the last of the same
has occurred.

     3. Representations and Warranties of the Company. The Company hereby represents and
warrants to the Investor as follows:

     3.1 Organization, Standing and Power. The Company is duly organized, validly
existing and in good standing under the laws of the State of Delaware and has the requisite
power and authority to carry on its business as now being conducted.

     3.2 Authority; Binding Obligations. The Company has all requisite power and
authority to enter into this Agreement and to consummate the Transactions. The execution
and delivery of this Agreement by the Company and the consummation by the Company of the
Transactions have been duly authorized by all necessary action on the part of the Company.
This Agreement has been duly executed and delivered by, and constitutes the valid and
binding obligation of, the Company, enforceable against the Company in accordance with its
terms, subject to the effect of applicable bankruptcy, insolvency, reorganization,
moratorium and other similar laws affecting the rights of creditors generally and the effect
of general principles of equity. The Amended Series AA Certificate, when executed,
delivered and filed with the Secretary of State of Delaware, will be duly executed and
delivered by, and constitute the valid and binding obligation of, the Company, enforceable
against the Company in accordance with its terms.

     3.3 Capitalization. The authorized capital stock of the Company consists of
50,000,000 shares of Common Stock and 1,000,000 shares of preferred stock, $0.001 par value
per share, of which 25,000 shares are designated as Series AA Stock and 25,000 are
designated as Series A junior participating preferred stock (“Junior Preferred”). As of
March 31, 2006, there were (i) 5,836,609 shares of Common Stock issued and outstanding, (ii)
3,167,258 shares of Common Stock held in the treasury of the Company or held by any
subsidiary of the Company; (iii) 683,914 shares of Common Stock reserved for issuance under
the Company’s stock option plans upon exercise of authorized but unissued stock options;
(iv) 1,998,793 shares of Common Stock issuable

3

 

upon exercise of outstanding stock options issued under the Company’s stock option
plans; (v) 25,000 shares of Series AA Stock issued and outstanding; and (vi) no shares of
Junior Preferred issued or outstanding. All shares of Common Stock issuable pursuant to the
terms of the Series AA Stock and the Common Warrants (as amended) have been reserved and
kept available for issuance by the Board of Directors of the Company.

     3.4 Non-Contravention. The execution and delivery of this Agreement does not,
and the consummation of the Transactions and compliance with the provisions hereof will not,
conflict with, or result in any breach or violation of, or default (with or without notice
or lapse of time, or both) under, or give rise to a right of termination, cancellation or
acceleration of or “put” right with respect to any obligation or to loss of a benefit under,
or result in the creation of any pledges, claims, liens, charges, encumbrances and security
interests of any kind or nature (collectively, “Liens”) upon its properties or assets under
(i) the Company’s Certificate of Incorporation, (ii) any loan or credit agreement, note,
bond, mortgage, indenture, lease, contract or other agreement, instrument, permit,
concession, franchise or license applicable to the Company or any of its properties or
assets which is material to the Company, each as amended to date or (iii) any judgment,
order, decree, statute, law, ordinance, rule, regulation or arbitration award applicable to
the Company (including the rules and regulations of the Nasdaq Stock Market), or its
properties or assets, other than, in the case of clauses (ii) and (iii), any such conflicts,
breaches, violations, defaults, rights, losses or Liens that individually or in the
aggregate would not have a material adverse effect with respect to the Company or would not
prevent or materially hinder or delay the ability of the Company to consummate the
Transactions.

     3.5 Valid Issuance. The Warrant Shares upon receipt of the consideration
called for in the Common Warrants (as amended), will be duly authorized, validly issued,
fully paid and non-assessable and free and clear of any lien, security interest, option or
other charge or encumbrance, and free of all preemptive and other third party rights.

     3.6 Rights Agreement. Consummation of the Transactions will not result in any
of the Investor or its affiliates becoming an “Acquiring Person” under the Rights Agreement
dated as of March 15, 2006, between the Company and Continental Stock Transfer & Trust
Company, as amended by the Rights Amendment (defined in Section 3.8 below).

     3.7 Stockholder Approval. The Company has received the requisite approval of
its common stockholders for the Amended Series AA Certificate.

     3.8 Amendment of Rights Agreement. The Company has entered into an amendment
of the Rights Agreement dated as of March 15, 2006, between the Company and Continental
Stock Transfer & Trust Company providing that the consummation of the Transactions will not
result in any of the Investor or its affiliates becoming an “Acquiring Person” thereunder
(the “Rights Amendment”).

4

 

     4. Representations of the Investor. The Investor represents to the Company that:

     4.1 Organization, Standing and Power. The Investor is duly organized, validly
existing and in good standing under the laws of the State of Delaware and has the requisite
power and authority to carry on its business as now being conducted.

     4.2 Authority. The Investor has all requisite power and authority to enter
into this Agreement and to consummate the Transactions. The execution and delivery of this
Agreement by the Investor and the consummation by the Investor of the Transactions have been
duly authorized by all necessary action on the part of the Investor. This Agreement has
been duly executed and delivered by, and constitutes the valid and binding obligation of,
the Investor, enforceable against the Investor in accordance with its terms, subject to the
effect of applicable bankruptcy, insolvency, reorganization, moratorium and other similar
laws affecting the rights of creditors generally and the effect of general principles of
equity.

     4.3 Non-contravention. The execution and delivery of this Agreement does not,
and the consummation of the Transactions and compliance with the provisions hereof will not,
conflict with, or result in any breach or violation of, or default (with or without notice
or lapse of time, or both) under, or give rise to a right of termination, cancellation or
acceleration of or “put” right with respect to any obligation or to loss of a benefit under,
or result in the creation of Liens upon its properties or assets under, (i) the Investor’s
Certificate of Formation or operating agreement, each as amended to date, (ii) any loan or
credit agreement, note, bond, mortgage, indenture, lease, contract or other agreement,
instrument, permit, concession, franchise or license applicable to the Investor or any of
its properties or assets which is material to the Investor, each as amended to date or (iii)
any judgment, order, decree, statute, law, ordinance, rule, regulation or arbitration award
applicable to the Investor, or its properties or assets, other than, in the case of clauses
(ii) and (iii), any such conflicts, breaches, violations, defaults, rights, losses or Liens
that individually or in the aggregate would not have a material adverse effect with respect
to the Investor or would not prevent or materially hinder or delay the ability of the
Investor to consummate the Transactions.

     4.4 Series AA Stock and Common Warrant Ownership. The Investor owns
beneficially and of record, and has good and valid title to, all of the Series AA Stock and
all of the Common Warrants, free and clear of any Liens. There are no agreements affecting
the right of the Investor to enter into this Agreement with respect to the Series AA Stock
or the Common Warrants.

     4.5 Brokers. No broker, investment banker, financial advisor or other person
is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or
commission in connection with the Transactions based upon arrangements made by or on behalf
of the Investor.

     4.6 Investor Status. The Investor has such knowledge and experience in
financial and business matters as to be capable of evaluating the merits and risks of its
investment in the Series AA Stock (as amended hereby), the Common Stock (issuable

5

 

upon conversion of the Series AA Stock), the Common Warrants (as amended) and the
Warrant Shares, and is able to bear the economic risks of such investment.

     4.7 Accredited Investor. The Investor is an “accredited investor” as defined
in Rule 501(a) under the 1933 Act. The Investor is acquiring the Series AA Stock (as
amended hereby) and the Common Warrants (as amended) for its own account and not with a view
to any resale, distribution or other disposition thereof (or the Common Stock issuable upon
conversion or exercise thereof) in violation of the United States securities laws.

     4.8 No Other Agreements. The Investor has made no other agreements,
arrangements or understandings concerning the Transactions or the Company or any of its
subsidiaries with (a) any director, officer, employee or consultant of the Company or any of
its subsidiaries, or (b) any stockholder beneficially owning at least 5% of the outstanding
Common Stock.

     5. Covenants and Other Agreements.

     5.1 Further Amendment of Series AA Certificate. The Company covenants and
agrees that at its next annual meeting of stockholders expected to be held in June 2007 (the
“2007 Annual Meeting”), it will seek the approval of its stockholders to further amend the
Amended Series AA Certificate to delete the last sentence of paragraph 2(iii), which
provides as follows: “Notwithstanding the foregoing, in no event shall the Conversion Price
be adjusted pursuant to this paragraph 2(iii) to less than the current market price per
share of Common Stock (determined as provided in paragraph 3(xii)) on the Exchange Date.”
(the “Subsequent Stockholder Approval”). Until such time as the Subsequent Stockholder
Approval is obtained, and an amendment to the Amended Series AA Certificate is filed with
the Secretary of State of Delaware deleting the last sentence of paragraph 2(iii), the
Company shall not pay any cash dividend on Common Stock. The Company also covenants and
agrees that no changes to paragraph 6 in the Certificate of Designation as reflected in the
Amended Series AA Certificate will impair or limit the Investor’s right to designate or
elect directors at a special meeting or by written consent, and that promptly following the
Closing, the Company will file an Amended and Restated Certificate of Designation in form
and substance reasonably satisfactory to the Investor.

     5.2 Standstill Agreement. Section 5.6 of the Purchase Agreement is hereby
amended in the following respects:

	 	(a)	 	the date of March 29, 2010 shall be deemed to
be March 29, 2012;
	 
	 	(b)	 	the capitalized term “Warrants” shall be deemed
to refer to the Common Warrants as amended pursuant to Section 1.3 of
this Agreement; and
	 
	 	(c)	 	the capitalized term “Series A Preferred Stock”
shall be deemed to refer to the Series AA Stock as amended pursuant to
the Amended Series AA Certificate.

6

 

     5.3 Registration Rights Agreement. The Registration Rights Agreement (as
defined in the Purchase Agreement) between the Investor and the Company, dated as of March
29, 2000, is hereby deemed amended, to the extent necessary, to provide that the term
“Registrable Securities” shall be deemed to include all shares of Common Stock issuable upon
conversion of the Series AA Stock (as amended hereby) or upon exercise of the Common
Warrants, as amended.

     5.4 Public Announcements. The Investor and the Company will consult with each
other before issuing, and provide each other the opportunity to review and comment upon, any
press release or other public statements with respect to the Transactions, and shall not
issue any such press release or make any such public statement prior to such consultation,
except as may be required by applicable law, court process or by obligations pursuant to any
listing agreement with any national securities exchange or as are agreed upon in advance.
The parties agree that the initial press release or releases to be issued with respect to
the Transactions shall be mutually agreed upon prior to the issuance thereof.

     5.5 Tax Treatment. The Investor and the Company agree that, for federal and
applicable state income tax purposes, they will treat the Transactions as deemed exchanges
of the Common Warrants and the Series AA Preferred Stock for new Common Warrants and new
Series AA Preferred Stock governed by Sections 368(a)(1)(E) and 354 of the Internal Revenue
Code of 1986, as amended (the “Code”), Section 1036 of the Code, or all such sections (and
corresponding provisions of state income tax law), in which no gain or loss is recognized by
the Investor for such purposes. The parties shall file their applicable tax returns in a
manner consistent with such treatment.

     5.6 Reservation of Shares. The Company will reserve and keep available at all
times shares of Common Stock for the purpose of enabling the Company to satisfy its
obligations to issue shares of Common Stock pursuant to the terms of the Series AA Stock and
the Common Warrants (as amended).

     6. Miscellaneous.

     6.1 Entire Agreement. This Agreement, the Purchase Agreement (as amended
hereby), the Registration Rights Agreement (as amended hereby), the Warrants (as amended
hereby), and the exhibits hereto and thereto and the other documents referenced herein and
therein constitute the entire understanding and agreement of the parties hereto with respect
to the subject matter hereof and thereof and supersede all prior and contemporaneous
agreements or understandings, inducements or conditions, express or implied, written or
oral, between the parties with respect hereto and thereto.

     6.2 Governing Law. This Agreement will be governed by and construed in
accordance with the laws of the State of Delaware regardless of the laws that might
otherwise govern under applicable principles of conflicts of laws thereof.

     6.3 Assignment. Neither this Agreement nor any of the rights, interests or
obligations under this Agreement shall be assigned, in whole or in part, by operation of

7

 

law or otherwise, by any of the parties without the prior written consent of the other
parties. Any assignment in violation of the preceding sentence shall be void. Subject to the
preceding two sentences, this Agreement will be binding upon, inure to the benefit of, and
be enforceable by, the parties and their respective successors and assigns.

     6.4 Enforcement. The parties agree that irreparable damage would occur in the
event that any of the provisions of this Agreement were not performed in accordance with
their specific terms or were otherwise breached. It is accordingly agreed that the parties
shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and
to enforce specifically the terms and provisions of this Agreement in any court of the State
of Delaware or of the United States located in the State of Delaware in the event any
dispute arises out of this Agreement or any of the Transactions, and each party agrees (a)
it will not attempt to deny or defeat personal jurisdiction or venue in any such court by
motion or other request for leave from any such court and (b) it will not bring any action
relating to this Agreement or any of the Transactions in any court other than any such
court.

     6.5 Severability. Whenever possible, each provision or portion of any provision
of this Agreement will be interpreted in such manner as to be effective and valid under
applicable law but if any provision or portion of any provision of this Agreement is held to
be invalid, illegal or unenforceable in any respect under any applicable law or rule in any
jurisdiction, such invalidity, illegality or unenforceability will not affect any other
provision or portion of any provision in such jurisdiction, and this Agreement will be
reformed, construed and enforced in such jurisdiction as if such invalid, illegal or
unenforceable provision or portion of any provision had never been contained herein, so long
as the economic and legal substance of the Transactions are not affected in a manner
materially adverse to any party hereto.

     6.6 Further Assurances. The parties agree (i) to furnish upon request to each
other such further information, (ii) to execute and deliver to each other such other
documents, and (iii) to do such other acts and things, all as the other party may reasonably
request for the purpose of carrying out the intent of this Agreement and the documents
referred to in this Agreement.

     6.7 Construction. In entering into this Agreement, each party represents and
warrants that such party does so freely and voluntarily, after having had the opportunity to
meet and confer with such party’s respective attorneys regarding the contents and legal
effect of this Agreement. Each party represents and warrants that such party has full power
and authority to enter into and execute this Agreement. Every covenant, term, and provision
of this Agreement shall be construed simply according to its fair meaning and not strictly
for or against any party. In the event any claim is made by any party relating to any
conflict, omission, or ambiguity in this Agreement, no presumption or burden of proof or
persuasion shall be implied by virtue of the fact that this Agreement was prepared by or at
the request of a particular party or such party’s counsel.

8

 

     6.8 Amendment. This Agreement may be amended by mutual agreement of the parties
at any time, but only pursuant to an instrument in writing duly executed on behalf of each
of the Company and the Investor.

     6.9 Counterparts. This Agreement may be executed concurrently in two or more
counterparts, each of which will be deemed an original, but all of which together will
constitute one and the same instrument.

     6.10 Fees and Expenses. All fees and expenses incurred by the Investor in
connection with this Agreement and the Transactions, whether or not consummated, shall be
paid by the Company.

(Signature page follows)

9

 

     IN WITNESS WHEREOF, the Investor and the Company have caused this Agreement to be signed by
their respective officers hereunto duly authorized as of the date first written above.

	 	 	 	 	 
	 	CROWN EMAK PARTNERS, LLC
 

 	 
	 	/s/
JEFFREY S. DEUTSCHMAN
 	 
	 	Jeffrey S. Deutschman, its Manager 	 
	 	 	 
	 
 
	 	EMAK WORLDWIDE, INC.
 

 	 
	 	By:  	/s/
TERESA L. TORMEY
 	 
	 	 	Teresa L. Tormey, its Chief Administrative Officer	 
	 	 	 	 
	 

(Signature page to Exchange and Extension Agreement)

10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}]]